Transthyretin Silencing Therapies and the Cardiology Clinic: Selection, Cost and the Diagnostic Bottleneck Upstream. Journal of Heart and Cardiovascular Science, [S. l.], v. 4, n. 1, p. 1–4, 2023. DOI: 10.5281/zenodo.22345291. Disponível em: https://pragmajournals.org/index.php/JHCS/article/view/171. Acesso em: 30 oct. 2026.